VF
GMAB icon

Virtu Financial’s Genmab GMAB Stock Holding History

Virtu Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Buy
+14,517
New +$386K 0.01% 610
2026
Q1 		– Sell
-22,620
Closed -$697K – 1881
2025
Q4 		$697K Buy
+22,620
New +$705K 0.03% 472
2023
Q1 		– Sell
-7,308
Closed -$310K – 1723
2022
Q4 		$310K Buy
+7,308
New +$301K 0.04% 478

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Virtu Financial's GMAB Position: Q2 2026 in Review

Virtu Financial opened a new position in Genmab (GMAB) in Q2 2026: 14,517 shares worth $399K. The stake represents 0.01% of the portfolio and ranks #610 among its holdings. This is a return to the name: Virtu Financial previously reported a position in GMAB as recently as Q4 2025.

Virtu Financial first reported a position in GMAB in Q4 2022 and has held it in 3 quarters since. The position peaked at $697K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Virtu Financial held 14,517 shares of Genmab worth $399K as of Q2 2026.
  • Genmab was a new Virtu Financial position in Q2 2026.
  • Genmab made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #610 holding.
  • Virtu Financial first reported a position in Genmab in Q4 2022 and has held it in 3 quarters since.
  • Virtu Financial's Genmab position peaked at $697K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.